0001179110-20-007757.txt : 20200624
0001179110-20-007757.hdr.sgml : 20200624
20200624174659
ACCESSION NUMBER: 0001179110-20-007757
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200623
FILED AS OF DATE: 20200624
DATE AS OF CHANGE: 20200624
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GILMAN STEVEN C
CENTRAL INDEX KEY: 0001379970
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50797
FILM NUMBER: 20986550
MAIL ADDRESS:
STREET 1: 110 HARTWELL AVENUE
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MOMENTA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001235010
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 043561634
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617 491-9700
MAIL ADDRESS:
STREET 1: 301 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
edgar.xml
FORM 4 -
X0306
4
2020-06-23
0
0001235010
MOMENTA PHARMACEUTICALS INC
MNTA
0001379970
GILMAN STEVEN C
C/O MOMENTA PHARMACEUTICALS, INC
301 BINNEY STREET
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (Right to Buy)
38.09
2020-06-23
4
A
0
25000
0
A
2030-06-23
Common Stock
25000
25000
D
Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan. The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Gilman's continued service to the Company.
/s/ R. Mark Chamberlin as attorney in fact
2020-06-24